Composition for promoting collagen synthesis, collagen synthesis accelerator and application thereof

Through a collagen synthesis promoter that combines a specific proportion of amino acids with hyaluronic acid compounds, the allergic reactions and cytotoxicity problems of collagen supplementation methods in the prior art are solved, and safe and effective collagen synthesis is achieved, which is suitable for Dermatology and trauma repair.

CN118948670APending Publication Date: 2024-11-15EYEBRIGHT MEDICAL TECH BEIJING
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411080082.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-07
Publication Date
2024-11-15

AI Technical Summary

Technical Problem

In the prior art, supplementing collagen to the skin by in situ injection of collagen or using mixed amino acid solutions may lead to allergic reactions after implantation, cytotoxicity or local tissue allergic reactions, and cannot effectively promote the synthesis of collagen in skin tissue.

Method used

Provided is a composition that promotes collagen synthesis, containing hyaluronic acid compounds, glycyl tyrosine, proline, valine and leucine, combined with hyaluronic acid by specific mass ratios and concentration ratios. The hydrating and moisturizing ability of compounds and the antioxidant ability of glycyl tyrosine induce cells to synthesize collagen and form a safe and effective collagen synthesis promoter.

Benefits of technology

This composition can not only safely promote the synthesis of collagen in skin tissue, improve the moisturizing properties and antioxidant ability of the skin, reduce the risk of allergic reactions, but also be suitable for the fields of dermatological medical beauty, tissue repair and trauma repair, and has broad application prospects.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004983467820000061
    Figure BDA0004983467820000061
  • Figure BDA0004983467820000071
    Figure BDA0004983467820000071
  • Figure BDA0004983467820000081
    Figure BDA0004983467820000081
Patent Text Reader

Abstract

The invention provides a composition for promoting collagen synthesis, a collagen synthesis accelerant and application of the collagen synthesis accelerant. The composition for promoting collagen synthesis is prepared from the following components in parts by mass: 3 to 7 parts of hyaluronic acid compounds, 0.1 to 0.3 part of glycyl tyrosine, 0.5 to 1.5 parts of proline, 0.4 to 1.5 parts of valine and 0.2 to 0.9 part of leucine, wherein the weight-average molecular weight of the hyaluronic acid compound is 100,000-3,000,000, and the hyaluronic acid compound comprises at least one of hyaluronic acid and hyaluronate. According to the composition for promoting collagen synthesis provided by the invention, specific types of amino acids are mutually matched with sodium hyaluronate and glycyl tyrosine, so that cells can be induced and promoted to synthesize collagen, and the composition has moisturizing and antioxidant capacities; the method has a wide application prospect in the fields of skin medical cosmetology, tissue repair, wound repair and the like.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present application relates to the technical field of biomedical materials, and in particular to a composition for promoting collagen synthesis, a collagen synthesis promoter and applications thereof. Background Art

[0002] As one of the most abundant proteins in mammals, collagen is widely distributed in connective tissues such as tendons, bones, cartilage, skin, and cornea. From a physiological perspective, collagen provides cells with a suitable living environment and promotes cell adhesion, proliferation, and migration. Therefore, during wound repair, collagen can mediate rapid healing and promote wound healing. Collagen can be divided into different types according to the different amino acid compositions of collagen. The dermis of human skin mainly contains type I collagen, which forms a fibrous scaffold that provides elasticity and strength to the skin.

[0003] When affected by environmental factors or aging, the collagen in the skin denatures or degrades, and the skin loses its elasticity and strength, resulting in wrinkles. The current solution to this problem is to supplement collagen for the skin by injecting collagen in situ. However, due to differences in the properties of collagen, collagen raw materials extracted from other animal tissues, such as cowhide, pig skin, and bovine Achilles tendon, may have the risk of allergic reactions after implantation. Some researchers also choose to use a compound amino acid mixed solution to promote the synthesis of collagen in skin tissue. However, different types and concentrations of amino acids have different effects on the synthesis of collagen in skin tissue. Inappropriate types and dosages of amino acids may lead to cytotoxicity or local tissue allergic reactions and fail to achieve the desired effect.

[0004] In view of this, this application is hereby filed. Summary of the invention

[0005] The main purpose of the present application is to provide a composition for promoting collagen synthesis, a collagen synthesis promoter and its application, so as to solve the problem that the existing technology uses in situ injection of collagen to supplement collagen for the skin, which may cause allergic reactions after implantation, and the use of a compound amino acid mixed solution to promote the synthesis of collagen in skin tissue, which may cause cytotoxicity or local tissue allergic reactions.

[0006] In order to achieve the above-mentioned purpose, according to one aspect of the present application, a composition for promoting collagen synthesis is provided, which is composed of the following components in parts by mass: 3-7 parts of hyaluronic acid compounds, 0.1-0.3 parts of glycyltyrosine, 0.5-1.5 parts of proline, 0.4-1.5 parts of valine, and 0.2-0.9 parts of leucine; wherein the weight-average molecular weight of the hyaluronic acid compounds is 100,000-3 million, and the hyaluronic acid compounds include at least one of hyaluronic acid and hyaluronate.

[0007] Furthermore, in the above composition, the mass ratio of valine to proline is 0.9-1.1; and / or the mass ratio of leucine to proline is 0.45-0.55.

[0008] Furthermore, in the above composition, the amount of hyaluronic acid compounds is 4-6 parts, preferably 4-5 parts, and more preferably 4.5-5 parts; the amount of glycyltyrosine is 0.15-0.3 parts, preferably 0.2-0.3 parts, and more preferably 0.2-0.25 parts; the amount of proline is 0.6-1.2 parts, preferably 0.75-1.1 parts, and more preferably 0.9-1.1 parts; the amount of valine is 0.5-1.2 parts, preferably 0.675-1.1 parts, and more preferably 0.9-1.1 parts; the amount of leucine is 0.4-0.9 parts, preferably 0.42-0.55 parts, and more preferably 0.45-0.55 parts.

[0009] Furthermore, the weight average molecular weight of the hyaluronic acid compound is 100,000-2,000,000, preferably 200,000-1,500,000, and more preferably 300,000-900,000.

[0010] According to the second aspect of the present application, a collagen synthesis promoter is also provided, which comprises the composition provided in the first aspect and water, wherein the concentration of hyaluronic acid compounds is 3-7 mg / mL, the concentration of glycyltyrosine is 0.1-0.3 mg / mL, the concentration of proline is 0.5-1.5 mg / mL, the concentration of valine is 0.4-1.5 mg / mL, and the concentration of leucine is 0.2-0.9 mg / mL.

[0011] Furthermore, in the above-mentioned collagen synthesis promoter, the concentration of hyaluronic acid compounds is 4-6 mg / mL, preferably 4-5 mg / mL, and more preferably 4.5-5 mg / mL; the concentration of glycyltyrosine is 0.15-0.3 mg / mL, preferably 0.2-0.3 mg / mL, and more preferably 0.2-0.25 mg / mL; the concentration of proline is 0.6-1.2 mg / mL, preferably 0.75-1.1 mg / mL, and more preferably 0.9-1.1 mg / mL; the concentration of valine is 0.5-1.2 mg / mL, preferably 0.675-1.1 mg / mL, and more preferably 0.9-1.1 mg / mL; the concentration of leucine is 0.4-0.9 mg / mL, preferably 0.42-0.55 mg / mL, and more preferably 0.45-0.55 mg / mL.

[0012] Furthermore, the dynamic viscosity of the collagen promoter is 5-100 mPa.s, preferably 20-100 mPa; and / or the total amount of heavy metals in the collagen synthesis promoter is not more than 5 μg / g.

[0013] Furthermore, the transmittance of the collagen synthesis promoter within the wavelength range of 300nm-800nm ​​is not less than 98%.

[0014] Furthermore, the absorbance of the collagen synthesis promoter at a wavelength of 260 nm is not greater than 1.0, preferably not greater than 0.3.

[0015] Furthermore, the osmotic pressure molar concentration of the collagen synthesis promoter is not greater than 350 mOsmol / kg, preferably not greater than 305 mOsmol / kg.

[0016] Furthermore, when the collagen synthesis promoter is used to culture cells in vitro, the cell survival rate is not less than 95%, preferably not less than 97%.

[0017] According to the third aspect of the present application, there is also provided the use of the composition for promoting collagen synthesis provided in the first aspect or the collagen synthesis promoter provided in the second aspect in the fields of medical cosmetology, tissue repair or wound repair.

[0018] According to the fourth aspect of the present application, there is also provided the use of the composition for promoting collagen synthesis provided in the first aspect or the collagen synthesis promoter provided in the second aspect in dressings, facial masks, skin care products or medical beauty injections.

[0019] The technical solution of the present application is applied. The present application considers that the synthesis of proteins in the body complies with the "barrel theory", abandons the existing design idea of ​​compounding multiple types of amino acids, selects specific types of amino acids in combination with the composition ratio of collagen itself, and limits the mass ratio of these amino acids to induce cells to synthesize collagen. At the same time, the hydrating and moisturizing ability of hyaluronic acid compounds is used to provide a water-rich environment for skin tissue, and the antioxidant ability of glycyltyrosine is used to promote cell repair. By combining specific types and specific dosages of each component to cooperate with each other, a safe composition that can better promote tissue collagen synthesis is provided.

[0020] The composition for promoting collagen synthesis provided in the present application can not only induce and promote cells to synthesize collagen through the cooperation of specific types of amino acids with hyaluronic acid compounds and glycyltyrosine, but also has moisturizing and antioxidant capabilities, and has broad application prospects in the fields of skin medical cosmetology, tissue repair, and wound repair. DETAILED DESCRIPTION

[0021] It should be noted that, in the absence of conflict, the embodiments and features in the embodiments of the present application can be combined with each other. The present application will be described in detail below in conjunction with the embodiments.

[0022] As analyzed in the background technology of this application, with age or the influence of environmental factors, the collagen in the skin denatures or degrades, causing the skin to lose elasticity and strength. The current solution is mainly to supplement collagen for the skin by injecting collagen in situ or to promote the synthesis of collagen in skin tissue by using a compounded amino acid mixed solution. However, due to the differences in the properties of collagen species, there may be a risk of allergic reactions after implantation, and inappropriate amino acid species and dosage compounding may cause cytotoxicity or local tissue allergic reactions. In order to solve these problems, the present application provides a composition for promoting collagen synthesis, a collagen synthesis promoter and its application.

[0023] In a first typical embodiment of the present application, a composition for promoting collagen synthesis is provided, which is composed of the following components in parts by mass: 3-7 parts of hyaluronic acid compounds, 0.1-0.3 parts of glycyltyrosine, 0.5-1.5 parts of proline, 0.4-1.8 parts of valine, and 0.2-0.9 parts of leucine; wherein the weight-average molecular weight of the hyaluronic acid compounds is 100,000-3 million, and the hyaluronic acid compounds include at least one of hyaluronic acid and hyaluronate.

[0024] In the present application, hyaluronate includes but is not limited to sodium hyaluronate, potassium hyaluronate and the like.

[0025] Hyaluronic acid is an important component of human skin, cartilage tissue and joint lubricating fluid. Hyaluronic acid molecules can carry more than 500 times their own weight in water and are currently recognized as the best moisturizing ingredient.

[0026] Glycyltyrosine is a dipeptide with some antioxidant capacity that plays a role in improving cellular immune function, reducing the risk of infection, and promoting cell repair. These properties make it a potential compound that is beneficial to cell health and repair.

[0027] This application takes into account that the synthesis of proteins in the body follows the "barrel theory", abandons the existing design ideas of multiple types of amino acid compounding, selects specific amino acid types in combination with the composition ratio of collagen itself, and limits the mass ratio of these amino acids to induce cells to synthesize collagen. At the same time, the hydrating and moisturizing ability of hyaluronic acid compounds is used to provide a water-rich environment for skin tissue, and the antioxidant ability of glycyltyrosine is used to promote cell repair. By combining specific types and specific dosages of each component to cooperate with each other, a safe composition that can better promote tissue collagen synthesis is provided.

[0028] The composition for promoting collagen synthesis provided in the present application can not only induce and promote cells to synthesize collagen through the cooperation of specific types of amino acids with hyaluronic acid compounds and glycyltyrosine, but also has moisturizing and antioxidant capabilities, and has broad application prospects in the fields of skin medical cosmetology, tissue repair, and wound repair.

[0029] In the composition for promoting protein synthesis provided in the present application, the hyaluronic acid compound is, by weight, 3 parts, 3.5 parts, 4 parts, 4.5 parts, 5 parts, 5.5 parts, 6 parts, 6.5 parts, 7 parts or a range of any two values; glycyl tyrosine is 0.1 parts, 0.15 parts, 0.2 parts, 0.25 parts, 0.3 parts or a range of any two values; proline is 0.5 parts, 0.6 parts, 0.675 parts, 0.7 parts, 0.75 parts, 0.8 parts, 0.9 parts, 1.0 parts, 1.1 parts, 1.2 parts or a range of any two values. valine is 0.4, 0.42, 0.45, 0.5, 0.6, 0.675, 0.7, 0.75, 0.8, 0.9, 1.0, 1.1, 1.2, 1.5 or a range value consisting of any two numerical values; leucine is 0.2, 0.3, 0.4, 0.42, 0.45, 0.5, 0.55, 0.6, 0.7, 0.8, 0.9 or a range value consisting of any two numerical values.

[0030] In the present application, the weight average molecular weight of hyaluronic acid compounds is such as 100,000, 200,000, 300,000, 500,000, 700,000, 800,000, 900,000, 1,000,000, 1,200,000, 1,500,000, 1,800,000, 2,000,000, 2,200,000, 2,500,000, 2,800,000, 3,000,000 or the range value of any two numerical values. The weight average molecular weight of hyaluronic acid compounds is too low, which is unfavorable for improving moisture retention, and the weight average molecular weight of hyaluronic acid compounds is too high, which is unfavorable for skin tissue absorption. Especially when the weight average molecular weight of hyaluronic acid compounds is 100,000-2,000,000, it is more beneficial for cell absorption, and then improves the moisture retention of skin.

[0031] In order to further improve the synthesis efficiency of skin tissue collagen, in some embodiments, the mass ratio of valine to proline is preferably 0.9-1.1, such as 0.9, 0.95, 1.00, 1.05, 1.1 or a range consisting of any two values.

[0032] In other embodiments, the mass ratio of leucine to proline is preferably 0.45-0.55, such as 0.45, 0.48, 0.50, 0.52, 0.55 or a range consisting of any two values.

[0033] In a second typical embodiment of the present application, a collagen synthesis promoter is also provided, which includes the composition for promoting collagen synthesis provided in the first typical embodiment and water, wherein the concentration of hyaluronic acid is 3-7 mg / mL, the concentration of glycyltyrosine is 0.1-0.3 mg / mL, the concentration of proline is 0.5-1.5 mg / mL, the concentration of valine is 0.4-1.8 mg / mL, and the concentration of leucine is 0.2-0.9 mg / mL.

[0034] It should be noted that, in the present application, concentration refers to the ratio of the mass of the component to the total volume of the collagen synthesis promoter (mg / mL).

[0035] The collagen synthesis promoter provided in the present application uses a composition that promotes collagen synthesis as an effective ingredient, and at the same time limits the concentrations of hyaluronic acid compounds, glycyltyrosine and different types of amino acids to induce cells to synthesize collagen. It can not only provide a water-rich environment for skin tissue, but also improve the antioxidant capacity of cells and promote cell repair. It has broad application prospects in the fields of skin medical cosmetology, tissue repair, and wound repair.

[0036] In this application, water varies according to the application scenario of collagen. If it is used as an injection in the body, the water is injection water. If it is applied on the skin surface, such as when used as an auxiliary material or a facial mask, the water is deionized water or purified water.

[0037] Typically but not limiting, in the collagen synthesis promoter provided in the present application, the concentration of the hyaluronic acid compound is 3 mg / mL, 3.5 mg / mL, 4 mg / mL, 4.5 mg / mL, 5 mg / mL, 5.5 mg / mL, 6 mg / mL, 6.5 mg / mL, 7 mg / mL or a range consisting of any two values; the concentration of glycyl tyrosine is 0.1 mg / mL, 0.15 mg / mL, 0.2 mg / mL, 0.25 mg / mL, 0.3 mg / mL or a range consisting of any two values; the concentration of proline is 0.5 mg / mL, 0.6 mg / mL, 0.7 mg / mL, 0.8 mg / mL, 0.9 mg / mL, 1.0 mg / mL, 1.1 mg / mL, 1.2 mg / mL, 1.5 mg / mL or any range consisting of any two values. the concentration of valine is 0.4 mg / mL, 0.5 mg / mL, 0.6 mg / mL, 0.7 mg / mL, 0.8 mg / mL, 0.85 mg / mL, 0.9 mg / mL, 0.95 mg / mL, 1.0 mg / mL, 1.05 mg / mL, 1.1 mg / mL, 1.2 mg / mL, 1.5 mg / mL, 1.8 mg / mL or a range value consisting of any two numerical values; the concentration of leucine is 0.2 mg / mL, 0.3 mg / mL, 0.4 mg / mL, 0.45 mg / mL, 0.48 mg / mL, 0.50 mg / mL, 0.52 mg / mL, 0.55 mg / mL, 0.6 mg / mL, 0.8 mg / mL, 0.9 mg / mL or a range value consisting of any two numerical values.

[0038] In order to further accelerate the synthesis efficiency of skin collagen, in some embodiments, the concentration of hyaluronic acid compounds in the collagen synthesis promoter is preferably 4-6 mg / mL, more preferably 4-5 mg / mL, and further preferably 4.5-5 mg / mL; the concentration of glycyltyrosine is 0.15-0.3 mg / mL, further preferably 0.2-0.3 mg / mL, and further preferably 0.2-0.25 mg / mL; the concentration of proline is 0.6-1.2 mg / mL, further preferably 0.75-1.1 mg / mL, and further preferably 0.9-1.1 mg / mL; the concentration of valine is 0.5-1.2 mg / mL, further preferably 0.675-1.1 mg / mL, and further preferably 0.9-1.1 mg / mL; the concentration of leucine is 0.4-0.9 mg / mL, further preferably 0.42-0.55 mg / mL, and further preferably 0.45-0.55 mg / mL.

[0039] In some embodiments, the viscosity of the collagen synthesis promoter provided in the present application is 5-100 mPa.s, preferably 20-100 mPa.s, to further improve its ability to be used as an injection solution.

[0040] In other embodiments, the total amount of heavy metals in the collagen synthesis promoter provided by the present application is no more than 5 μg / g, so as to further improve its safety and reduce allergenicity.

[0041] In some embodiments, the transmittance of the collagen synthesis promoter within the wavelength range of 300nm-800nm ​​is not less than 98%, so as to improve the glossiness of the skin.

[0042] In other embodiments, the absorbance of the collagen synthesis promoter at a wavelength of 260 nm is no greater than 1.0, preferably no greater than 0.3.

[0043] In one embodiment, the osmotic pressure molar concentration of the collagen synthesis promoter is not greater than 350mOsmol / kg, preferably not greater than 305mOsmol / kg, so as to improve the absorption rate of the skin.

[0044] In other embodiments, the collagen synthesis promoter is used for in vitro cell culture, and the cell survival rate is not less than 95%, preferably not less than 97%, so as to improve its biosafety.

[0045] In a third typical embodiment of the present application, there is provided the use of the composition for promoting collagen synthesis provided by the first typical embodiment or the collagen synthesis promoter provided by the second typical embodiment in the field of dermatological cosmetology, tissue repair or wound repair.

[0046] The composition for promoting collagen synthesis or the collagen synthesis promoter provided in the present application can not only improve the dull and dehydrated state of the skin, but also accelerate the healing of skin wounds, and has broad application prospects in the fields of medical cosmetology, tissue repair or wound repair.

[0047] In the fourth typical embodiment of the present application, there is also provided the use of the composition for promoting collagen synthesis provided in the above-mentioned first typical embodiment or the collagen synthesis promoter provided in the second typical embodiment in dressings, facial masks, skin care products or medical beauty injections.

[0048] The composition for promoting collagen synthesis or the collagen synthesis promoter provided in the present application can be prepared into a dressing or a mask for use in skin tissue repair after minor injuries, such as wound and skin care after cosmetic surgery.

[0049] The composition for promoting collagen synthesis or the collagen synthesis promoter provided in the present application can be injected into the facial dermis as a skin medical cosmetic product to promote tissue collagen synthesis and improve the dull and dehydrated state of the skin.

[0050] The composition for promoting collagen synthesis or the collagen synthesis promoter provided in the present application can also be applied to the skin surface after injury to accelerate the healing of skin injury.

[0051] The beneficial effects of the present application will be further illustrated below in combination with embodiments and comparative examples.

[0052] Examples 1-9 respectively provide a collagen synthesis promoter, which is prepared by adding a composition for promoting collagen synthesis to a total volume of 1000 mL of injection water, and stirring until the composition is completely dissolved to form a viscous uniform solution, thereby obtaining the collagen synthesis promoter.

[0053] The specific components and dosages of the composition for promoting collagen synthesis in Examples 1-9 are shown in Table 1 below.

[0054] Table 1

[0055]

[0056] Comparative Examples 1-15

[0057] Comparative Examples 1-15 respectively provide a collagen synthesis promoter, which differs from Example 1 in that the composition of the composition promoting collagen synthesis is different. The specific components and amounts of the composition promoting collagen synthesis in Comparative Examples 1-15 are shown in Table 2 below.

[0058] Table 2

[0059]

[0060]

[0061] Test Example 1

[0062] The collagen synthesis promoters provided in the examples and comparative examples were tested for dynamic viscosity and heavy metal content, and the results are shown in Table 3 below.

[0063] Among them, (1) the test method for dynamic viscosity is: at (25±0.2)°C, use a cone and plate viscometer to measure according to the third method of rotational viscometer measurement method in 0633 Viscosity Measurement Method of the Pharmacopoeia of the People's Republic of China (Volume 4) (2020 Edition).

[0064] (2) The method for detecting heavy metal content is: determine the total amount of heavy metals [measured in terms of lead (Pb)] according to the third method of heavy metal inspection method 0821 of the Pharmacopoeia of the People's Republic of China (Volume 4) (2020 edition).

[0065] Table 3

[0066]

[0067]

[0068] From the above description, it can be seen that the above embodiments of the present application achieve the following technical effects: the dynamic viscosity of the collagen promoter provided in the embodiments of the present application is 5-100 mPa.s, so that it can not only be applied externally to the skin, but also can be injected into the body.

[0069] In addition, the heavy metal content of the collagen promoter provided in the embodiment of the present application is ≤5 μg / g, which has higher safety when used on the human body and can further reduce allergies.

[0070] Test Example 2

[0071] The transmittance at a wavelength of 300nm-800nm, the absorbance at a wavelength of 260nm and the osmotic submolar concentration of the collagen synthesis promoter provided in the examples and comparative examples were tested respectively, and the results are shown in Table 4 below.

[0072] Among them, (1) the test method for the transmittance of collagen synthesis promoter at a wavelength of 300nm-800nm ​​is: according to the ultraviolet-visible spectrophotometry method in Part 4 0401 of the Chinese Pharmacopoeia (2020 edition), the spectral transmittance in the range of 300nm to 1100nm is recorded.

[0073] (2) The test method for the absorbance of collagen synthesis promoter at a wavelength of 260 nm is as follows: Determine according to the UV-visible spectrophotometry method in 0401 of the Pharmacopoeia of the People's Republic of China (Volume IV) (2020 Edition).

[0074] (3) The test method for the osmotic pressure molar concentration of the collagen synthesis promoter is: determined according to the osmotic pressure molar concentration determination method 0632 of the "Pharmacopoeia of the People's Republic of China (Volume IV)" (2020 edition).

[0075] Table 4

[0076]

[0077]

[0078] From the above description, it can be seen that the above-mentioned embodiments of the present application achieve the following technical effects: the transmittance of the collagen promoter provided in the embodiments of the present application within the wavelength range of 300nm-800nm ​​is not less than 98%, the absorbance at a wavelength of 260nm is not greater than 0.3, and the osmotic pressure molar concentration is not greater than 305mOsmol / kg, which is more suitable for the human body.

[0079] Test Example 3

[0080] After the collagen promoters provided in the examples and comparative examples were sterilized by wet heat, in vitro cytotoxicity evaluation was performed according to GB / T16886.5-2017. The qualitative evaluation was based on the following Table 5. The quantitative evaluation was based on the MTT method. The test results are shown in the following Table 6.

[0081] Table 5

[0082]

[0083] Table 6

[0084]

[0085]

[0086] From the above description, it can be seen that the above embodiments of the present application achieve the following technical effects: when the collagen synthesis promoter provided by the embodiments of the present application is used for in vitro cell culture, the cell survival rate is not less than 97%, and it has excellent biosafety.

[0087] Test Example 4

[0088] The collagen promoter provided in the example and the comparative example was filtered through a 0.2 μm membrane, and then mixed with DMEM culture medium at a ratio of 0.05 g / mL to obtain a collagen promoter culture solution for standby use.

[0089] After adult primary dermal fibroblasts were grown on the wall, the cells were washed with PBS and the culture medium was replaced with the above-mentioned collagen promoter culture medium. After 1, 3, and 7 days of culture, the cultured cells were lysed and the collagen content in the lysate was detected using a human type I collagen ELISA kit, and the significant difference in the results was calculated. The results are shown in Table 7.

[0090] Table 7

[0091]

[0092]

[0093] Note: Comparative Examples 1-5 were too cytotoxic and not suitable for cell growth, so they were not tested.

[0094] From the above description, it can be seen that the above embodiments of the present application achieve the following technical effects: the collagen promoter provided in the embodiments of the present application is mixed with the culture medium to culture adult primary dermal fibroblasts, which can effectively promote the synthesis of collagen by fibroblasts.

[0095] Test Example 4

[0096] The collagen promoters provided in the examples and comparative examples were subjected to animal skin sensitization tests according to GB / T 16886.10-2017, using guinea pigs as test subjects, wherein the allergy grade classification standards are shown in Table 8, and the animal skin sensitization results are shown in Table 9.

[0097] Table 8

[0098]

[0099] Table 9

[0100]

[0101]

[0102] Note: The cytotoxicity of comparative example 1-5 was too high to be suitable for sensitization test, so it was not tested.

[0103] From the above description, it can be seen that the above embodiments of the present application achieve the following technical effects: the collagen synthesis promoter provided by the embodiments of the present application has no obvious allergenicity and has excellent biosafety.

[0104] Test Example 5

[0105] Thirty female volunteers aged 20-40 years who had undergone facial beauty treatment were randomly selected and divided into three groups, with 10 people in each group. The collagen promoters provided by Examples 5-6 and Comparative Example 9 were filtered through a 0.2 μm membrane and distributed to the three groups of volunteers respectively.

[0106] The volunteers applied the samples immediately after completing facial beauty treatments, and then applied the samples at night on the 1st, 2nd, and 3rd days. No other interface products, skin care products, or repair products were used during this period. The volunteers only washed their faces with water every morning. The skin tissue grade evaluation criteria are shown in Table 10, and the test results of the volunteers are shown in Table 11.

[0107] Table 10

[0108]

[0109]

[0110] Table 11

[0111]

[0112] From the above description, it can be seen that the above embodiments of the present application achieve the following technical effects: the collagen synthesis promoter provided in Examples 5-6 of the present application is used as a skin care product and can be directly applied to the skin surface after trauma to accelerate the healing of skin trauma.

[0113] Test Example 6

[0114] Six female volunteers aged 20-40 were recruited and randomly divided into two groups. The collagen promoters provided in Example 6 and Comparative Example 10 were respectively filled into syringes for wet heat sterilization and then injected into the faces of the volunteers using a Demasha water light machine in combination with a nine-needle pillow. The moisture content of the stratum corneum and the skin glossiness were tested using a German CK multifunctional skin tester before the injection, 7 days after the injection, and 14 days after the injection. The results are shown in Table 12 below, where the test values ​​are the average values ​​of each group.

[0115] Table 12

[0116]

[0117] From the above description, it can be seen that the above-mentioned embodiments of the present application achieve the following technical effects: the collagen synthesis promoter provided in Example 6 of the present application is injected into the facial dermis as a skin medical beauty product, which can promote the synthesis of fibroblast collagen and improve the dull and dehydrated state of the skin.

[0118] The above description is only the preferred embodiment of the present application and is not intended to limit the present application. For those skilled in the art, the present application may have various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present application shall be included in the protection scope of the present application.

Claims

1. A composition for promoting collagen synthesis, characterized in that: The composition is composed of the following components in parts by mass: 3-7 parts of hyaluronic acid compounds, 0.1-0.3 parts of glycyltyrosine, 0.5-1.5 parts of proline, 0.4-1.5 parts of valine, and 0.2-0.9 parts of leucine; wherein the weight average molecular weight of the hyaluronic acid compounds is 100,000-3,000,000, and the hyaluronic acid compounds include at least one of hyaluronic acid and hyaluronate.

2. The composition according to claim 1, characterized in that In the composition, the mass ratio of valine to proline is 0.9-1.1; and / or the mass ratio of leucine to proline is 0.45-0.

55.

3. The composition according to claim 1, characterized in that In the composition, the amount of the hyaluronic acid compound is 4-6 parts by weight, preferably 4-5 parts, and more preferably 4.5-5 parts; The amount of glycyltyrosine is 0.15-0.3 parts, preferably 0.2-0.3 parts, and more preferably 0.2-0.25 parts; The amount of proline is 0.6-1.2 parts, preferably 0.75-1.1 parts, and more preferably 0.9-1.1 parts; The amount of valine is 0.5-1.2 parts, preferably 0.675-1.1 parts, and more preferably 0.9-1.1 parts; The amount of leucine is 0.4-0.9 parts, preferably 0.42-0.55 parts, and more preferably 0.45-0.55 parts; Preferably, the weight average molecular weight of the hyaluronic acid compound is 100,000-2,000,000, preferably 200,000-1,500,000, and more preferably 300,000-900,000.

4. A collagen synthesis promoter, characterized in that The collagen synthesis promoter comprises the composition of any one of claims 1 to 3 and water, wherein the concentration of hyaluronic acid compounds is 3-7 mg / mL, the concentration of glycyltyrosine is 0.1-0.3 mg / mL, the concentration of proline is 0.5-1.5 mg / mL, the concentration of valine is 0.4-1.5 mg / mL, and the concentration of leucine is 0.2-0.9 mg / mL.

5. The collagen synthesis promoter according to claim 4, characterized in that In the collagen synthesis promoter, the concentration of the hyaluronic acid compound is 4-6 mg / mL, preferably 4-5 mg / mL, and more preferably 4.5-5 mg / mL; The concentration of glycyltyrosine is 0.15-0.3 mg / mL, preferably 0.2-0.3 mg / mL, and more preferably 0.2-0.25 mg / mL; The concentration of proline is 0.6-1.2 mg / mL, preferably 0.75-1.1 mg / mL, and more preferably 0.9-1.1 mg / mL; The concentration of valine is 0.5-1.2 mg / mL, preferably 0.675-1.1 mg / mL, and more preferably 0.9-1.1 mg / mL; The concentration of leucine is 0.4-0.9 mg / mL, preferably 0.42-0.55 mg / mL, and more preferably 0.45-0.55 mg / mL.

6. The collagen synthesis promoter according to claim 4 or 5, characterized in that The dynamic viscosity of the collagen synthesis promoter is 5-100 mPa.s, preferably 20-100 mPa; And / or, the total amount of heavy metals in the collagen synthesis promoter is no more than 5 μg / g.

7. The collagen synthesis promoter according to claim 4 or 5, characterized in that The transmittance of the collagen synthesis promoter in the wavelength range of 300nm-800nm ​​is not less than 98%; And / or, the absorbance of the collagen synthesis promoter at a wavelength of 260 nm is not greater than 1.0, preferably not greater than 0.

3.

8. The collagen synthesis promoter according to claim 4 or 5, characterized in that The osmotic pressure molar concentration of the collagen synthesis promoter is not more than 350mOsmol / kg, preferably not more than 305mOsmol / kg; And / or, the collagen synthesis promoter is used for in vitro cell culture, and the cell survival rate is not less than 95%, preferably not less than 97%.

9. Use of the composition for promoting collagen synthesis according to any one of claims 1 to 3 or the collagen synthesis promoter according to any one of claims 4 to 8 in the fields of medical cosmetology, tissue repair or wound repair.

10. Use of the composition for promoting collagen synthesis according to any one of claims 1 to 3 or the collagen synthesis promoter according to any one of claims 4 to 8 in dressings, facial masks, skin care products or medical beauty injections.